Literature DB >> 8248189

RNA enzyme-directed gene therapy.

S Altman1.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8248189      PMCID： PMC47887          DOI： 10.1073/pnas.90.23.10898

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  18 in total

1.  Ribozymes as potential anti-HIV-1 therapeutic agents.

Authors:  N Sarver; E M Cantin; P S Chang; J A Zaia; P A Ladne; D A Stephens; J J Rossi
Journal:  Science       Date:  1990-03-09       Impact factor: 47.728

2.  Inhibition of Moloney murine leukemia virus-induced leukemia in transgenic mice expressing antisense RNA complementary to the retroviral packaging sequences.

Authors:  L Han; J S Yun; T E Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

Review 3.  Specific regulation of gene expression by antisense, sense and antigene nucleic acids.

Authors:  C Hélène; J J Toulmé
Journal:  Biochim Biophys Acta       Date:  1990-06-21

4.  Efficient trans cleavage and a common structural motif for the ribozymes of the human hepatitis delta agent.

Authors:  A D Branch; H D Robertson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

5.  'Hairpin' catalytic RNA model: evidence for helices and sequence requirement for substrate RNA.

Authors:  A Hampel; R Tritz; M Hicks; P Cruz
Journal:  Nucleic Acids Res       Date:  1990-01-25       Impact factor: 16.971

6.  Sequence-specific endoribonuclease activity of the Tetrahymena ribozyme: enhanced cleavage of certain oligonucleotide substrates that form mismatched ribozyme-substrate complexes.

Authors:  A J Zaug; C A Grosshans; T R Cech
Journal:  Biochemistry       Date:  1988-12-13       Impact factor: 3.162

7.  A small catalytic oligoribonucleotide.

Authors:  O C Uhlenbeck
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

8.  Self-cleavage of virusoid RNA is performed by the proposed 55-nucleotide active site.

Authors:  A C Forster; R H Symons
Journal:  Cell       Date:  1987-07-03       Impact factor: 41.582

9.  Resistance to human immunodeficiency virus type 1 (HIV-1) infection in human CD4+ lymphocyte-derived cell lines conferred by using retroviral vectors expressing an HIV-1 RNA-specific ribozyme.

Authors:  M Weerasinghe; S E Liem; S Asad; S E Read; S Joshi
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

10.  Functional characterization of a U5 ribozyme: intracellular suppression of human immunodeficiency virus type 1 expression.

Authors:  B Dropulić; N H Lin; M A Martin; K T Jeang
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103
View more
  23 in total

1.  Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli.

Authors:  P Trang; M Lee; E Nepomuceno; J Kim; H Zhu; F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 2.  Molecular therapy in ocular wound healing.

Authors:  M F Cordeiro; G S Schultz; R R Ali; S S Bhattacharya; P T Khaw
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

3.  Cross-clade inhibition of HIV-1 replication and cytopathology by using RNase P-associated external guide sequences.

Authors:  Gunter Kraus; Rebeca Geffin; Gina Spruill; Andrea K Young; Rachel Seivright; Diana Cardona; Jennifer Burzawa; H James Hnatyszyn
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

4.  Comparison of the specificities and catalytic activities of hammerhead ribozymes and DNA enzymes with respect to the cleavage of BCR-ABL chimeric L6 (b2a2) mRNA.

Authors:  T Kuwabara; M Warashina; T Tanabe; K Tani; S Asano; K Taira
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

5.  Expression of lexA targeted ribozyme in Escherichia coli BL-21 (DE3) cells.

Authors:  Ramesh Singh Yadava; Ravindra Kumar; Pramod Kumar Yadava
Journal:  Mol Cell Biochem       Date:  2005-03       Impact factor: 3.396

6.  Chloromycetin resistance of clinically isolated E coli is conversed by using EGS technique to repress the chloromycetin acetyl transferase.

Authors:  Mei-Ying Gao; Chuan-Rui Xu; Ru Chen; Shou-Gui Liu; Jiang-Nan Feng
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

Review 7.  Evolutionary perspective on the structure and function of ribonuclease P, a ribozyme.

Authors:  N R Pace; J W Brown
Journal:  J Bacteriol       Date:  1995-04       Impact factor: 3.490

8.  Effective inhibition of influenza virus production in cultured cells by external guide sequences and ribonuclease P.

Authors:  D Plehn-Dujowich; S Altman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

9.  A ribozyme specifically suppresses transformation and tumorigenicity of Ha-ras-oncogene-transformed NIH/3T3 cell lines.

Authors:  M Y Chang; S J Won; H S Liu
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

10.  Artificial regulation of gene expression in Escherichia coli by RNase P.

Authors:  C Guerrier-Takada; Y Li; S Altman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.